Miriam Merad
Principal Investigator
Dr. Miriam Merad is Dean of Translational Research and Therapeutic Innovation; Inaugural Chair of the Department of Immunology & Immunotherapy; Robin Chemers Neustein Professor of Immunology; and Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai in New York.
She is an internationally acclaimed physician-scientist and a leader in the fields of immunology and oncology. Dr. Merad’s work spans multiple areas of immune biology, and her discoveries have reshaped immunology textbooks by revealing previously unrecognized complexity within the immune system and redefining its role in several major human diseases. She is particularly renowned for her pioneering research on macrophages and their contributions to cancer, inflammatory conditions, and age-associated diseases. Her laboratory now focuses on developing macrophage-targeted therapies to treat cancer and inflammatory diseases and to prevent age-related disorders.
Merad has authored more than 300 primary research articles and reviews in high-impact journals, with her work cited several thousand times. As Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at Mount Sinai, she spearheads multiple initiatives that accelerate immunotherapy development, fostering cross-disciplinary collaboration to translate discovery into transformative patient therapies.
Dr. Merad is Past President of the International Union of Immunological Societies (IUIS). She is an elected member of the National Academy of Sciences and the National Academy of Medicine, and a fellow of the American Association for Cancer Research Academy and the Academy of Immuno-Oncology. Her contributions have been recognized with numerous prestigious honors, including the William B. Coley Award, the Leopold Griffuel Cancer Prize, the INSERM International Prize, the Sjöberg Prize from the Royal Swedish Academy of Sciences, and she was named “Chevalier de la legion d’honneur (Knight of the legion of honor)” by the French Republic.